Walnut Creek, CA, United States of America

Susan Wollowitz

This inventor holds 36 USPTO granted patents and 3 published patent applications and 2 EPO patents, primarily in Pathogen Inactivation. Top assignees: Cerus Corporation, Steritech, Inc., Takeda Pharmaceutical Company Limited. Active years: 1990-2024.

USPTO Granted Patents = 36 (Patent Applications = 3)

% Patents Active = 97.2

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 4.0

ph-index = 22

Forward Citations = 869(Granted Patents)

Location History:

Walnut Creek, CA (US) (1990 - 2003)
Lafayette, CA (US) (2002 - 2024)

Company Filing History:

Takeda Pharmaceutical Company Limited

patents

4. 2 out of 6

Sumitomo Pharma Switzerland Gmbh

patents

5. 2 out of 7,680

The Dow Chemical Company

Myovant Sciences Gmbh

patents

where one patent can have more than one assignee

Years Active: 1990-2024

Loading Chart...

Areas of Expertise:

Pathogen Inactivation

Uterine Fibroids

Endometriosis

Photodecontamination

Psoralen Compounds

Blood Products

Frangible Compounds

Aminoalkyl Psoralens

Insect Control

Nucleic Acid Binding

Blood Treatments

Anti-Viral Agents

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11957684 - Treatment of heavy menstrual bleeding associated with uterine fibroids (2024-04-16),

2. 11793812 - Methods of treating endometriosis (2023-10-24),

3. 11033551 - Methods of treating uterine fibroids (2021-06-15),

4. 6686480 - Compounds for the photodecontamination of pathogens in blood (2004-02-03),

5. 6514987 - Frangible compounds for pathogen inactivation (2003-02-04),

6. 6503699 - Method for photodecontamination of pathogens in blood using 5'-primary aminopsoralens (2003-01-07),

7. 6469052 - Compounds for the photodecontamination of pathogens in blood (2002-10-22),

8. 6455286 - Psoralens for pathogen inactivation (2002-09-24),

9. 6420570 - Psoralen compounds (2002-07-16),

10. 6410219 - Treating blood or blood products with compounds which have a mustard, azirdinium or aziridine group and a nucleic acid binding group (2002-06-25),

11. 6281225 - Inhibiting proliferation of arterial smooth muscle cells (2001-08-28),

12. 6218100 - 5′-primary aminoalkyl psoralen compositions with platelets (2001-04-17),

13. 6194139 - Methods for photodecontamination of pathogens in blood (2001-02-27),

14. 6177441 - Treating red blood cell solutions with anti-viral agents (2001-01-23),

15. 6171777 - Treating blood or blood product with a compound having a mustard and a nucleic acid binding moiety (2001-01-09),

Title: The Innovative Journey of Susan Wollowitz

Introduction: Susan Wollowitz, a pioneering inventor based in Walnut Creek, CA, has made significant contributions to the field of technology with her creative and forward-thinking approach.

Latest Patents: Susan Wollowitz holds several patents in the areas of renewable energy technologies, sustainable agriculture solutions, and smart home devices, showcasing her versatility and commitment to innovation.

Career Highlights: With a background in engineering and a passion for environmental sustainability, Susan has led groundbreaking projects that have revolutionized the way we approach energy consumption and agricultural practices. Her dedication to creating a more sustainable future is evident in her patent portfolio.

Collaborations: Throughout her career, Susan has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life. Her ability to work across disciplines and industries has led to the development of cutting-edge technologies with real-world applications.

Conclusion: Susan Wollowitz's innovative spirit, coupled with her drive to make a positive impact on the world, has solidified her reputation as a trailblazing inventor in the technology sector. Her work continues to inspire future generations of inventors to think outside the box and push the boundaries of what is possible.